STEREOTAXIS INC (STXS)
US85916J4094 - Common Stock
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
Stereotaxis will host first-quarter financial results on May 13, 2024. ...
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
7 Penny Stocks That Could 5X by the End of 2024
These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold.
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Reports 2023 Full Year Financial Results
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
Intermountain Medical Center becomes the first hospital in the Intermountain region and in Utah to adopt the latest in robotic heart care technology. ...
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
Stereotaxis announces first patients treated using new Magnetic Interventional Catheter, MAGiC...
Inspire Medical names Intuitive Surgical CMO to board (NYSE:INSP)
Inspire Medical Systems (INSP) has appointed Intuitive Surgical (ISRG) Chief Medical Officer Dr. Myriam Curet as an independent director to its board. Read more here.
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
Baptist Health Lexington has become one of the first in the world to provide the latest in robotic technology to treat arrhythmias...
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
Stereotaxis Chairman and CEO, David Fischel, will again participate in the Piper Sandler Healthcare Conference. ...
Stereotaxis Reports 2023 Third Quarter Financial Results
ST. LOUIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
Stereotaxis (NYSE: STXS) & Abbott (NYSE:ABT) announce the first patients in the US have been treated successfully utilizing combined technologies...
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis director acquires further indirect stake (NYSE:STXS)
Stereotaxis (STXS) Director Isaac Paul J has acquired $37,907.2 worth of indirect ownership in the healthcare company.Arbiter Partners Capital Management, controlled by Isaac,...
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment
ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium
ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Reports 2023 Second Quarter Financial Results
ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
ST. LOUIS, July 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients
ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application of MAGiC Catheter
ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...